The following table presents the fair values of the Company's derivative financial instruments included in the Consolidated Balance Sheets as of July 31, 2026, January 31, 2026 and July 31, 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives |
|
|
Liability Derivatives |
|
|
|
Balance
Sheet
Location |
|
July 31,
2026
Fair
Value |
|
|
January 31,
2026
Fair
Value |
|
|
July 31,
2025
Fair
Value |
|
|
Balance
Sheet
Location |
|
July 31,
2026
Fair
Value |
|
|
January 31,
2026
Fair
Value |
|
|
July 31,
2025
Fair
Value |
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Exchange Contracts |
|
Other Current
Assets |
|
$ |
67 |
|
|
$ |
— |
|
|
$ |
— |
|
|
Accrued
Liabilities |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
728 |
|
Total Derivative Instruments |
|
|
|
$ |
67 |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
728 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Derivatives |
|
|
Liability Derivatives |
|
|
|
Balance
Sheet
Location |
|
July 31,
2026
Fair
Value |
|
|
January 31,
2026
Fair
Value |
|
|
July 31,
2025
Fair
Value |
|
|
Balance
Sheet
Location |
|
July 31,
2026
Fair
Value |
|
|
January 31,
2026
Fair
Value |
|
|
July 31,
2025
Fair
Value |
|
Derivatives not designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Exchange Contracts |
|
Other Current
Assets |
|
$ |
20 |
|
|
$ |
484 |
|
|
$ |
113 |
|
|
Accrued
Liabilities |
|
$ |
145 |
|
|
$ |
10 |
|
|
$ |
251 |
|
Total Derivative Instruments |
|
|
|
$ |
20 |
|
|
$ |
484 |
|
|
$ |
113 |
|
|
|
|
$ |
145 |
|
|
$ |
10 |
|
|
$ |
251 |
|
|